Published 1991 | Version v1
Book

Potential breast tumor imaging agents: Fluorotamoxifen and derivatives

  • 1. Univ. of Texas M.D. Anderson Cancer Center, Houston (United States)
  • 2. Univ. of Texas Health Science Center, Houston (United States)

Description

This study is aimed at developing a ligand to be used for imaging estrogen receptor positive breast tumors by Positron Emission Tomography (PET). We describe the synthesis of fluorotamoxifen analogs with the fluorine atom positioned on the aliphatic side chain of tamoxifen and the measurement of the in vitro binding of fluorotamoxifens to estrogen receptors. N,N-Diethylfluorotamoxifen was prepared from the tosyl ester of the corresponding hydroxy derivative. 18F-Labeled N,N-diethylfluoromethyltamoxifen was prepared in 60% yield. These studies indicate that fluorinated tamoxifens have high affinity for estrogen receptors and can be labeled with 18F, thus reflecting a potential for use in imaging estrogen receptors by PET

Part of:
New trends in radiopharmaceutical synthesis, quality assurance, and regulatory control

Additional details

Publishing Information

Publisher
Plenum Press.
Imprint Place
New York, NY (United States)
Imprint Title
New trends in radiopharmaceutical synthesis, quality assurance, and regulatory control
Imprint Pagination
529 p.
Journal Page Range
p. 67-77.

Conference

Title
200. American Chemical Society (ACS) national meeting.
Dates
26-31 Aug 1990.
Place
Washington, DC (United States).

Optional Information

Secondary number(s)
CONF-900802--.